Smart tool for cholesterol after stroke or mini-stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a smart computer tool that helps doctors manage your cholesterol treatment with Evolocumab (Repatha). If you have had a recent stroke or mini-stroke and are already taking this medicine, the tool may help you reach your LDL (bad cholesterol) goal faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a stroke or a mini-stroke (TIA) in the last 3 months. The cause was not a heart problem or irregular heartbeat.
- Your doctor has already prescribed a cholesterol-lowering medicine called Evolocumab (Repatha).
- You have not had a bleeding stroke, brain tumor, or other serious brain condition.
- You haven't taken Evolocumab or a similar medicine in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different LDL cholesterol targets after a small vessel stroke to find the best level for preventing another stroke. If you've had this type of stroke, you may be able to help doctors decide the right treatment goal.
This trial tests whether adding an intensive cholesterol-lowering drug (called a PCSK9 inhibitor) to standard care can reduce the risk of another stroke or heart attack in people who recently had a stroke from narrowed brain or neck arteries. It is a high-dose approach designed to rapidly lower cholesterol and may offer extra protection for those with high Lp(a).
This trial tests whether a cholesterol-lowering medicine (called a PCSK9 inhibitor) can help people who recently had a stroke caused by a narrowed artery in the brain. The goal is to see if it reduces the risk of another stroke or helps recovery.
This trial tests whether adding a PCSK9 inhibitor to standard statin therapy can help people with narrowing in brain arteries that hasn't caused symptoms yet. The goal is to see if this combination lowers plaque and prevents future strokes.
This study tests two approaches together: a computer-based brain training program and a stronger cholesterol-lowering medicine, to see if they can help improve memory and thinking in people with narrowed brain arteries. You would be randomly assigned to different combinations of the two, and the doctors will monitor your progress.
This study tests whether starting a cholesterol-lowering injection (a PCSK9 inhibitor) early after a heart attack can slow or shrink the buildup of plaque in other heart arteries that are not the one that was stented. If you have two other arteries with mild blockages, this treatment might help prevent future heart problems.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.